News
Efficient distribution, dissipating stigma and an emphasis on decentralized trials are all working in favor of digital treatments, according to a panel of digital therapeutics executives and industry stakeholders.
Panelists at DTx East discuss the difference between 510(k) clearances and enforcement discretions, and why research should go beyond the FDA threshold.
Initially, Amwell planned to sell 35 million shares between $14 and $16 with up to 5.2 million additional shares for underwriters.
A new analysis of published RCTs did see significant benefits among short-term and single-focus app interventions, but noted that "relatively few high-quality studies have been conducted" in this area.
The LumiHealth app is available in the App Store for pre-order now, and the two-year program will be offered from late October 2020.
Activist short seller Citron Research called the Israeli digital X-ray company out on its limited R&D expenditure, suspicious distribution agreements and other factors. Nanox has described the report as incorrect and misleading.
Notable's voice-powered assistant was developed to help curb the time doctors spend on charting.
The offering, consisting of original workout content tightly integrated with Apple Watch features, was announced at a virtual event yesterday.
The 900-participant study uses learnings from Apple's Tueo Health acquisition and could inform the development of a digital biomarker for asthma.
The watch measures oxygen and energy levels, tracks menstrual cycles, and gives insights into running, biking and swimming workouts.